SCHEMBL30080944

SCHEMBL30080944

NC(=O)c1nc(-c2ccncc2)oc1NCC(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 9/20 0.48
IRAK4 Q9NWZ3 5/20 0.38
MAP2K3 P46734 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
MAPK14 Q16539 1/20 0.38
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1384983 0.72 IKBKB (0.67) IKBKBKDM4EHSD17B10PPARGNCOA2
SCHEMBL22609532 0.69 IKBKB (0.49) IKBKBMAP2K3KDM4EHSD17B10PPARG
SCHEMBL4088592 0.65 IKBKB (1.00) IKBKB
SCHEMBL626644 0.65 IKBKB (0.54) IKBKBMAP2K3KDM4EHSD17B10PPARG
SCHEMBL31198739 0.63 IKBKB (0.63) IKBKBKDM4EHSD17B10PPARGNCOA2
SCHEMBL15639467 0.63 SIRT3 (0.46) IRAK4KDM4EALDH1A1
SCHEMBL30106359 0.63 GSK3B (0.51) IKBKBPPARG
SCHEMBL3123539 0.62 NPC1 (0.50) IKBKBMAP2K3NPC1RAB9AJAK2
SCHEMBL3124862 0.62 IKBKB (0.71) IKBKBMAP2K3KDM4EHSD17B10PPARG
SCHEMBL3114611 0.61 IKBKB (0.62) IKBKBKDM4EPPARGNPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054573-A1 TOPICAL COMPOSITIONS COMPRISING IRAK4 INHIBITORS FOR USE IN TREATING DERMATOLOGICAL CONDITIONS CHARACTERISED BY INFLAMMATION Dermira, Inc (US) 2022-09-14 EP claimed
EP-4054573-A1 TOPICAL COMPOSITIONS COMPRISING IRAK4 INHIBITORS FOR USE IN TREATING DERMATOLOGICAL CONDITIONS CHARACTERISED BY INFLAMMATION Dermira, Inc (US) 2022-09-14 EP disclosed